| 结直肠癌的新辅助治疗 |
| |
| 引用本文： | 王红霞,李杰. 结直肠癌的新辅助治疗[J]. 中华肿瘤防治杂志, 2006, 13(5): 394-396 |
| |
| 作者姓名： | 王红霞 李杰 |
| |
| 作者单位： | 上海第二医科大学附属新华医院肿瘤科,上海,200002;上海第二医科大学附属新华医院肿瘤科,上海,200002 |
| |
| 摘 要： | 新辅助治疗在提高可切除性结直肠癌患者的手术率和生存率方面取得一些可喜结果。以奥沙利铂、依立替康为基础联合化疗,在提高转移性结直肠癌患者手术率与生存率疗效已较为肯定。肝动脉介入治疗(如HAI、TACE等)在新辅助治疗中的应用疗效有待进一步研究。术前PVE和两步肝切除术可提高手术安全性和切除率。
|
| 关 键 词： | 结直肠肿瘤 直肠肿瘤 综述文献 |
| 文章编号： | 1673-5269(2006)05-0394-03 |
| 修稿时间： | 2005-01-10 |
Neoadjuvant therapy of colorectal cancer |
| |
| WANG Hong-xia,LI Jie. Neoadjuvant therapy of colorectal cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2006, 13(5): 394-396 |
| |
| Authors: | WANG Hong-xia LI Jie |
| |
| Abstract: | Neoadjuvant therapy has shown clear benefits in the treatment of operable colorectal cancer.Systemic chemotherapy including new drugs such as CPT-11 and oxaliplatin has shown improved operation rate and survival rate.Intra-arterial hepatic treatment such as HAI and TACE needs the further research.PVE and two-stage hepatectomy can raise the operation safety and excision rates. |
| |
| Keywords: | colorectal neoplasms rectal neoplasms review literature |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
